The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Generate:Biomedicines Appoints Kym White As Chief Corporate Affairs Officer and Promotes Lisa Wyman To Chief Technical Operations Officer
PUBLIC · GENBApr 30, 2024•about 2 years ago
Position
Chief Technical Operations Officer
Company
Generate:Biomedicines
Lisa Wyman
Somerville
Description
Generate:Biomedicines has welcomed Kimberly (Kym) White as the new Chief Corporate Affairs Officer and promoted Lisa Wyman to Chief Technical Operations Officer. These appointments reflect the company’s commitment to gender diversity and aim to transform the landscape of drug discovery and development.
Company Information
Company
Generate:Biomedicines
Location
Somerville, Massachusetts, United States
About
Generate:Biomedicines is the first drug generation company pioneering a machine learning-powered generative biology platform with the ability to create new drugs on demand across a wide range of biologic modalities. The Generate Platform – which is a continuous loop to generate, build, measure, and learn – can drastically increase the speed at which targets and therapeutics are identified and validated. This will improve the specificity of target engagement by generated proteins and reduce the time and cost of identifying and developing clinical candidates. Generate:Biomedicines is a clinical stage company that was founded by Flagship Pioneering after two years of foundational research in its Labs unit and launched in 2020. Learn more about Generate:Biomedicines by visiting https://generatebiomedicines.com/ or following the company on Twitter and LinkedIn.